Tissue | Expression Dynamics | Abbreviation |
Cervix | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Cervix/EPB41L5_pca_on_diff_genes.png) | CC: Cervix cancer |
HSIL_HPV: HPV-infected high-grade squamous intraepithelial lesions |
N_HPV: HPV-infected normal cervix |
Endometrium | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Endometrium/EPB41L5_pca_on_diff_genes.png) | AEH: Atypical endometrial hyperplasia |
EEC: Endometrioid Cancer |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/EPB41L5_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/EPB41L5_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Lung | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Lung/EPB41L5_pca_on_diff_genes.png) | AAH: Atypical adenomatous hyperplasia |
AIS: Adenocarcinoma in situ |
IAC: Invasive lung adenocarcinoma |
MIA: Minimally invasive adenocarcinoma |
Skin | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Skin/EPB41L5_pca_on_diff_genes.png) | AK: Actinic keratosis |
cSCC: Cutaneous squamous cell carcinoma |
SCCIS:squamous cell carcinoma in situ |
Thyroid | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Thyroid/EPB41L5_pca_on_diff_genes.png) | ATC: Anaplastic thyroid cancer |
HT: Hashimoto's thyroiditis |
PTC: Papillary thyroid cancer |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00510998 | Lung | IAC | positive regulation of binding | 34/2061 | 173/18723 | 5.58e-04 | 7.76e-03 | 34 |
GO:00300486 | Lung | IAC | actin filament-based movement | 27/2061 | 127/18723 | 5.70e-04 | 7.89e-03 | 27 |
GO:00433938 | Lung | IAC | regulation of protein binding | 37/2061 | 196/18723 | 7.28e-04 | 9.60e-03 | 37 |
GO:00511007 | Lung | IAC | negative regulation of binding | 32/2061 | 162/18723 | 7.30e-04 | 9.60e-03 | 32 |
GO:00320926 | Lung | IAC | positive regulation of protein binding | 20/2061 | 85/18723 | 7.54e-04 | 9.82e-03 | 20 |
GO:01501173 | Lung | IAC | positive regulation of cell-substrate junction organization | 10/2061 | 33/18723 | 2.18e-03 | 2.15e-02 | 10 |
GO:0006929 | Lung | IAC | substrate-dependent cell migration | 8/2061 | 23/18723 | 2.28e-03 | 2.22e-02 | 8 |
GO:00163312 | Lung | IAC | morphogenesis of embryonic epithelium | 28/2061 | 147/18723 | 2.65e-03 | 2.44e-02 | 28 |
GO:00604852 | Lung | IAC | mesenchyme development | 47/2061 | 291/18723 | 4.61e-03 | 3.64e-02 | 47 |
GO:00320915 | Lung | IAC | negative regulation of protein binding | 19/2061 | 94/18723 | 6.26e-03 | 4.48e-02 | 19 |
GO:00487623 | Lung | IAC | mesenchymal cell differentiation | 39/2061 | 236/18723 | 6.33e-03 | 4.51e-02 | 39 |
GO:00018372 | Lung | IAC | epithelial to mesenchymal transition | 28/2061 | 157/18723 | 6.84e-03 | 4.75e-02 | 28 |
GO:000716012 | Lung | AIS | cell-matrix adhesion | 60/1849 | 233/18723 | 2.19e-12 | 2.55e-09 | 60 |
GO:003158913 | Lung | AIS | cell-substrate adhesion | 80/1849 | 363/18723 | 3.80e-12 | 3.16e-09 | 80 |
GO:000704413 | Lung | AIS | cell-substrate junction assembly | 34/1849 | 95/18723 | 8.17e-12 | 5.29e-09 | 34 |
GO:015011513 | Lung | AIS | cell-substrate junction organization | 34/1849 | 101/18723 | 5.74e-11 | 2.09e-08 | 34 |
GO:001081013 | Lung | AIS | regulation of cell-substrate adhesion | 55/1849 | 221/18723 | 7.48e-11 | 2.49e-08 | 55 |
GO:004804112 | Lung | AIS | focal adhesion assembly | 31/1849 | 87/18723 | 7.71e-11 | 2.49e-08 | 31 |
GO:005189313 | Lung | AIS | regulation of focal adhesion assembly | 26/1849 | 66/18723 | 1.99e-10 | 5.52e-08 | 26 |
GO:009010913 | Lung | AIS | regulation of cell-substrate junction assembly | 26/1849 | 66/18723 | 1.99e-10 | 5.52e-08 | 26 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EPB41L5 | SNV | Missense_Mutation | | c.391C>T | p.Arg131Cys | p.R131C | Q9HCM4 | protein_coding | deleterious(0) | probably_damaging(0.912) | TCGA-A7-A26F-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | taxotere | SD |
EPB41L5 | SNV | Missense_Mutation | | c.966C>G | p.Phe322Leu | p.F322L | Q9HCM4 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AR-A0TX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
EPB41L5 | SNV | Missense_Mutation | | c.1851N>T | p.Met617Ile | p.M617I | Q9HCM4 | protein_coding | tolerated_low_confidence(0.5) | benign(0.003) | TCGA-BH-A0DK-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Hormone Therapy | tamoxiphen | SD |
EPB41L5 | SNV | Missense_Mutation | novel | c.1279N>T | p.Pro427Ser | p.P427S | Q9HCM4 | protein_coding | tolerated(0.54) | benign(0.075) | TCGA-D8-A1JF-01 | Breast | breast invasive carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
EPB41L5 | SNV | Missense_Mutation | | c.274N>C | p.Ala92Pro | p.A92P | Q9HCM4 | protein_coding | tolerated(0.09) | probably_damaging(0.994) | TCGA-D8-A27F-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin+cyclophosphamide | SD |
EPB41L5 | SNV | Missense_Mutation | novel | c.1900G>A | p.Glu634Lys | p.E634K | Q9HCM4 | protein_coding | deleterious_low_confidence(0.04) | benign(0.214) | TCGA-VS-A9UP-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
EPB41L5 | SNV | Missense_Mutation | | c.473C>T | p.Thr158Ile | p.T158I | Q9HCM4 | protein_coding | deleterious(0.03) | probably_damaging(0.989) | TCGA-AA-3502-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
EPB41L5 | SNV | Missense_Mutation | | c.563N>C | p.Arg188Thr | p.R188T | Q9HCM4 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-3697-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
EPB41L5 | SNV | Missense_Mutation | | c.2079A>T | p.Lys693Asn | p.K693N | Q9HCM4 | protein_coding | tolerated_low_confidence(0.4) | benign(0.007) | TCGA-AA-3875-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
EPB41L5 | SNV | Missense_Mutation | rs150028843 | c.433C>G | p.Gln145Glu | p.Q145E | Q9HCM4 | protein_coding | deleterious(0.04) | possibly_damaging(0.892) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |